drugset / Trial / NCT00830830

TREAD-20 Extension - Treatment of Knee Pain Due to Osteoarthritis

NCT00830830

Phase 4 Completed 40 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

This extended study will evaluate the efficacy and safety of intra-articular injections of 20mg/2ml dose HYALGAN in patients with pain due to osteoarthritis (OA) of the knee.

Timeline

Start
2005-12
Primary completion
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Hyaluronate Other / unclassified 20 mg Other

Indications